Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Azacitidine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 69 Myelodysplastic Syndromes 25 Leukemia, Myelomonocytic, Chronic 14 Leukemia 7 Myeloproliferative Disorders 6 Anemia, Refractory, with Excess of Blasts 5 Leukemia, Biphenotypic, Acute 4 Hematologic Neoplasms 4 Recurrence 3 Lymphoma, T-Cell, Peripheral 3 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma 2 Leukemia, Neutrophilic, Chronic 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Hematologic Diseases 2 GATA2 Deficiency 2 Thrombocytosis 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Myeloid 1 Sarcoma 1 Polycythemia Vera 1 Pathologic Complete Response 1

Interventions

entrectinib 2 Magnetic Resonance Spectroscopy 2 tremelimumab 1 trametinib 1 selpercatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 X-Rays 1 Vemurafenib 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Specimen Handling 1 Mitoxantrone 1 Iodine-131 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡